The FDA has approved coated niacin (Niaspan, Abbott/Kos) extended-release tablets. Available since 1997, the product is indicated for boosting high-density lipoprotein-cholesterol (HDL-C) levels.
Three major clinical studies showed an average increase of 22% in HDL-C for patients receiving 2,000 mg of the product at bedtime.
discount drugs canda
Niacin has several indications, including reducing levels of total cholesterol, triglycerides, and apolipoprotein B; promoting the regression of coronary atherosclerosis; and reducing the risk of recurrent myocardial infarction.